{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:27:55Z","timestamp":1793744875288,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["P30CA047904"],"award-info":[{"award-number":["P30CA047904"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76583-8","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T05:02:58Z","timestamp":1729573378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2689-3199","authenticated-orcid":false,"given":"William H.","family":"Hicks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9437-0610","authenticated-orcid":false,"given":"Lauren C.","family":"Gattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-4247","authenticated-orcid":false,"given":"Mohamad El","family":"Shami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-8143","authenticated-orcid":false,"given":"Jeffrey I.","family":"Traylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7846-8055","authenticated-orcid":false,"given":"Diwakar","family":"Davar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-1664","authenticated-orcid":false,"given":"Yana G.","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7068-5517","authenticated-orcid":false,"given":"Timothy E.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9361-675X","authenticated-orcid":false,"given":"Samuel K.","family":"McBrayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5662-0829","authenticated-orcid":false,"given":"Kalil G.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"76583_CR1","doi-asserted-by":"publisher","first-page":"102083","DOI":"10.1016\/j.ctrv.2020.102083","volume":"89","author":"R Gutzmer","year":"2020","unstructured":"Gutzmer, R. et al. Melanoma brain metastases \u2013 interdisciplinary management recommendations 2020. Cancer Treat. Rev. 89, 102083. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102083 (2020).","journal-title":"Cancer Treat. Rev."},{"key":"76583_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11864-020-00733-z","volume":"21","author":"A Rishi","year":"2020","unstructured":"Rishi, A. & Yu, H. H. M. Current treatment of Melanoma Brain Metastasis. Curr. Treat. Options Oncol. 21, 45. https:\/\/doi.org\/10.1007\/s11864-020-00733-z (2020).","journal-title":"Curr. Treat. Options Oncol."},{"key":"76583_CR3","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/cncr.33459","volume":"127","author":"ED Bander","year":"2021","unstructured":"Bander, E. D. et al. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies. Cancer. 127, 2062\u20132073. https:\/\/doi.org\/10.1002\/cncr.33459 (2021).","journal-title":"Cancer"},{"key":"76583_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/s1470-2045(17)30429-1","volume":"18","author":"MA Davies","year":"2017","unstructured":"Davies, M. A. et al. Dabrafenib plus Trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Lancet Oncol. 18, 863\u2013873. https:\/\/doi.org\/10.1016\/s1470-2045(17)30429-1 (2017).","journal-title":"Lancet Oncol."},{"key":"76583_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa1805453","volume":"379","author":"HA Tawbi","year":"2018","unstructured":"Tawbi, H. A. et al. Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the brain. N Engl. J. Med. 379, 722\u2013730. https:\/\/doi.org\/10.1056\/NEJMoa1805453 (2018).","journal-title":"N Engl. J. Med."},{"key":"76583_CR6","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/S1470-2045(21)00545-3","volume":"22","author":"HA Tawbi","year":"2021","unstructured":"Tawbi, H. A. et al. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study. Lancet Oncol. 22, 1692\u20131704. https:\/\/doi.org\/10.1016\/S1470-2045(21)00545-3 (2021).","journal-title":"Lancet Oncol."},{"key":"76583_CR7","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ctrv.2013.06.004","volume":"39","author":"J Murrell","year":"2013","unstructured":"Murrell, J. & Board, R. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions. Cancer Treat. Rev. 39, 833\u2013838. https:\/\/doi.org\/10.1016\/j.ctrv.2013.06.004 (2013).","journal-title":"Cancer Treat. Rev."},{"key":"76583_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1200\/edbk_321137","volume":"41","author":"S Makawita","year":"2021","unstructured":"Makawita, S. & Tawbi, H. A. Nonsurgical Management of Melanoma Brain Metastasis: current therapeutics, challenges, and strategies for Progress. Am. Soc. Clin. Oncol. Educ. Book. 41, 79\u201390. https:\/\/doi.org\/10.1200\/edbk_321137 (2021).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"76583_CR9","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1002\/cncr.32375","volume":"125","author":"E Rulli","year":"2019","unstructured":"Rulli, E., Legramandi, L., Salvati, L. & Mandala, M. The impact of targeted therapies and immunotherapy in melanoma brain metastases: a systematic review and meta-analysis. Cancer. 125, 3776\u20133789. https:\/\/doi.org\/10.1002\/cncr.32375 (2019).","journal-title":"Cancer"},{"key":"76583_CR10","doi-asserted-by":"publisher","unstructured":"Zhou, S. et al. Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors. Front. Cell. Dev. Biology. 11https:\/\/doi.org\/10.3389\/fcell.2023.1166916 (2023).","DOI":"10.3389\/fcell.2023.1166916"},{"key":"76583_CR11","doi-asserted-by":"publisher","unstructured":"Kircher, D. A., Silvis, M. R., Cho, J. H. & Holmen, S. L. Melanoma Brain Metastasis: mechanisms, models, and Medicine. Int. J. Mol. Sci. 17https:\/\/doi.org\/10.3390\/ijms17091468 (2016).","DOI":"10.3390\/ijms17091468"},{"key":"76583_CR12","doi-asserted-by":"publisher","unstructured":"Hicks, W. H. et al. Contemporary Mouse Models in Glioma Research. Cells. 10https:\/\/doi.org\/10.3390\/cells10030712 (2021).","DOI":"10.3390\/cells10030712"},{"key":"76583_CR13","doi-asserted-by":"publisher","unstructured":"Sachs, N. et al. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. Cell 172, 373\u2013386.e310 https:\/\/doi.org\/https:\/\/doi.org\/ (2018). https:\/\/doi.org\/10.1016\/j.cell.2017.11.010","DOI":"10.1016\/j.cell.2017.11.010"},{"key":"76583_CR14","doi-asserted-by":"publisher","unstructured":"Pernik, M. N. et al. Patient-derived Cancer Organoids for Precision Oncology Treatment. J. Pers. Med. 11https:\/\/doi.org\/10.3390\/jpm11050423 (2021).","DOI":"10.3390\/jpm11050423"},{"key":"76583_CR15","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","volume":"10","author":"M Kim","year":"2019","unstructured":"Kim, M. et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat. Commun. 10, 3991. https:\/\/doi.org\/10.1038\/s41467-019-11867-6 (2019).","journal-title":"Nat. Commun."},{"key":"76583_CR16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/neuonc\/noab273","volume":"24","author":"KG Abdullah","year":"2022","unstructured":"Abdullah, K. G. et al. Establishment of patient-derived organoid models of lower-grade glioma. Neuro-oncology. 24, 612\u2013623. https:\/\/doi.org\/10.1093\/neuonc\/noab273 (2022).","journal-title":"Neuro-oncology"},{"key":"76583_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ccell.2022.07.011","volume":"40","author":"DD Shi","year":"2022","unstructured":"Shi, D. D. et al. De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma. Cancer cell. 40, 939\u2013956e916. https:\/\/doi.org\/10.1016\/j.ccell.2022.07.011 (2022).","journal-title":"Cancer cell."},{"key":"76583_CR18","doi-asserted-by":"publisher","first-page":"101408","DOI":"10.1016\/j.isci.2020.101408","volume":"23","author":"AE Vilgelm","year":"2020","unstructured":"Vilgelm, A. E. et al. Fine-needle aspiration-based patient-derived Cancer Organoids. iScience. 23, 101408. https:\/\/doi.org\/10.1016\/j.isci.2020.101408 (2020).","journal-title":"iScience"},{"key":"76583_CR19","doi-asserted-by":"publisher","first-page":"100220","DOI":"10.1016\/j.xpro.2020.100220","volume":"2","author":"CJ Phifer","year":"2021","unstructured":"Phifer, C. J. et al. Obtaining patient-derived cancer organoid cultures via fine-needle aspiration. STAR. Protocols. 2, 100220. https:\/\/doi.org\/10.1016\/j.xpro.2020.100220 (2021). https:\/\/doi.org\/https:\/\/doi.org\/","journal-title":"STAR. Protocols"},{"key":"76583_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","volume":"20","author":"S Zheng","year":"2022","unstructured":"Zheng, S. et al. SynergyFinder Plus: toward Better Interpretation and Annotation of Drug Combination Screening datasets. Genom. Proteom. Bioinform. 20, 587\u2013596. https:\/\/doi.org\/10.1016\/j.gpb.2022.01.004 (2022).","journal-title":"Genom. Proteom. Bioinform."},{"key":"76583_CR21","doi-asserted-by":"publisher","first-page":"117693512211007","DOI":"10.1177\/11769351221100754","volume":"21","author":"JD Buehler","year":"2022","unstructured":"Buehler, J. D. et al. Semi-automated computational Assessment of Cancer Organoid viability using Rapid Live-Cell Microscopy. Cancer Inf. 21, 11769351221100754. https:\/\/doi.org\/10.1177\/11769351221100754 (2022).","journal-title":"Cancer Inf."},{"key":"76583_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/pai.0000000000000097","volume":"23","author":"BC Willis","year":"2015","unstructured":"Willis, B. C., Johnson, G., Wang, J. & Cohen, C. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes. Appl. Immunohistochem. Mol. Morphol. 23, 109\u2013112. https:\/\/doi.org\/10.1097\/pai.0000000000000097 (2015).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"76583_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","volume":"18","author":"EZ Keung","year":"2018","unstructured":"Keung, E. Z. & Gershenwald, J. E. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev. Anticancer Ther. 18, 775\u2013784. https:\/\/doi.org\/10.1080\/14737140.2018.1489246 (2018).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"76583_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-22539-5_1","volume":"167","author":"B Shannan","year":"2016","unstructured":"Shannan, B., Perego, M., Somasundaram, R. & Herlyn, M. Heterogeneity in Melanoma. Cancer Treat. Res. 167, 1\u201315. https:\/\/doi.org\/10.1007\/978-3-319-22539-5_1 (2016).","journal-title":"Cancer Treat. Res."},{"key":"76583_CR25","doi-asserted-by":"crossref","unstructured":"Gregg, R. K. in In Melanoma: Methods and Protocols. 1\u201321 (eds Hargadon, K. M.) (Springer US, 2021).","DOI":"10.1007\/978-1-0716-1205-7_1"},{"key":"76583_CR26","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1158\/1078-0432.Ccr-21-0374","volume":"27","author":"S Yu","year":"2021","unstructured":"Yu, S. et al. A modified nucleoside 6-Thio-2\u2019-Deoxyguanosine exhibits Antitumor Activity in Gliomas. Clin. cancer Research: Official J. Am. Association Cancer Res. 27, 6800\u20136814. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-0374 (2021).","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res."},{"key":"76583_CR27","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1158\/1078-0432.Ccr-21-0833","volume":"28","author":"S Wei","year":"2022","unstructured":"Wei, S. et al. Antitumor Activity of a mitochondrial-targeted HSP90 inhibitor in Gliomas. Clin. cancer Research: Official J. Am. Association Cancer Res. 28, 2180\u20132195. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-0833 (2022).","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res."},{"key":"76583_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1136\/jcp.2005.025957","volume":"58","author":"L Zhuang","year":"2005","unstructured":"Zhuang, L. et al. Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. J. Clin. Pathol. 58, 1163\u20131169. https:\/\/doi.org\/10.1136\/jcp.2005.025957 (2005).","journal-title":"J. Clin. Pathol."},{"key":"76583_CR29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/1078-0432.Ccr-07-1440","volume":"14","author":"NK Haass","year":"2008","unstructured":"Haass, N. K. et al. The mitogen-activated protein\/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel. Clin. cancer Research: Official J. Am. Association Cancer Res. 14, 230\u2013239. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-1440 (2008).","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res."},{"key":"76583_CR30","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature09454","volume":"467","author":"G Bollag","year":"2010","unstructured":"Bollag, G. et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature. 467, 596\u2013599. https:\/\/doi.org\/10.1038\/nature09454 (2010).","journal-title":"Nature"},{"key":"76583_CR31","doi-asserted-by":"publisher","first-page":"eadg3358","DOI":"10.1126\/scitranslmed.adg3358","volume":"15","author":"S Ji","year":"2023","unstructured":"Ji, S. et al. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology. Sci. Transl. Med. 15, eadg3358. https:\/\/doi.org\/10.1126\/scitranslmed.adg3358 (2023).","journal-title":"Sci. Transl. Med."},{"key":"76583_CR32","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering, M. et al. Prospective derivation of a living Organoid Biobank of Colorectal Cancer patients. Cell. 161, 933\u2013945. https:\/\/doi.org\/10.1016\/j.cell.2015.03.053 (2015). https:\/\/doi.org\/https:\/\/doi.org\/","journal-title":"Cell"},{"key":"76583_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40778-022-00211-2","volume":"8","author":"WH Hicks","year":"2022","unstructured":"Hicks, W. H. et al. Creation and development of patient-derived organoids for therapeutic screening in Solid Cancer. Curr. Stem Cell Rep. 8, 107\u2013117. https:\/\/doi.org\/10.1007\/s40778-022-00211-2 (2022).","journal-title":"Curr. Stem Cell Rep."},{"key":"76583_CR34","doi-asserted-by":"publisher","first-page":"16399","DOI":"10.1038\/s41598-022-20487-y","volume":"12","author":"CC Chen","year":"2022","unstructured":"Chen, C. C. et al. Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors. Sci. Rep. 12, 16399. https:\/\/doi.org\/10.1038\/s41598-022-20487-y (2022).","journal-title":"Sci. Rep."},{"key":"76583_CR35","doi-asserted-by":"publisher","unstructured":"Jacob, F. et al. A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity. Cell 180, 188\u2013204 e122 (2020). https:\/\/doi.org\/10.1016\/j.cell.2019.11.036","DOI":"10.1016\/j.cell.2019.11.036"},{"key":"76583_CR36","doi-asserted-by":"publisher","first-page":"104614","DOI":"10.1016\/j.ebiom.2023.104614","volume":"92","author":"L Ou","year":"2023","unstructured":"Ou, L. et al. Patient-derived melanoma organoid models facilitate the assessment of immunotherapies. EBioMedicine. 92, 104614. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104614 (2023).","journal-title":"EBioMedicine"},{"key":"76583_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.29.542774","author":"M El Shami","year":"2023","unstructured":"El Shami, M. et al. Human plasma-like medium facilitates metabolic tracing and enables upregulation of immune signaling pathways in glioblastoma explants. bioRxiv. https:\/\/doi.org\/10.1101\/2023.05.29.542774 (2023).","journal-title":"bioRxiv"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76583-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T05:05:54Z","timestamp":1729573554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76583-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76583"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76583-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.18.576318","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patient tissue and blood samples were collected following ethical and technical guidelines on the use of human samples for biomedical research at the University of Pittsburgh after informed consent was obtained from patients under the Institutional Review Board Protocol (19080321). The study was conducted according to the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"Informed written consent was obtained from all individual participants included in this study. The authors affirm that human research participants provided informed consent for the publication of the images in Figs.\u00a02 and 3.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}}],"article-number":"24843"}}